It's Been All Downhill Since Cerebras Systems May IPO: 180% Gains Await According to This Wall Street Analyst

Impact · against what's priced in

CBRS faces a negative catalyst as the OpenAI pivot to NVDA directly threatens the high-growth inference revenue the market is already skeptical of, while the AMD partnership provides a tangible near-term proof point. NVDA and AMD see marginal gains as they are positioned as the beneficiaries of this shift, though these are largely incremental given their current valuations.

CBRS−0.60

Challenges what's priced in

The price assumes